7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Heart Failure and Transplant Cardiology
The management of heart failure has evolved significantly over the years, but for some patients, conventional treatments are not enough. Heart failure and transplant cardiology focus on advanced therapeutic interventions, including the use of ventricular assist devices (VADs) and heart transplantation. When heart failure reaches an advanced stage, a transplant may be the only option for survival, but this requires careful evaluation of the patient’s overall health and compatibility with a donor heart. Post-transplant care is equally crucial, involving immunosuppressive drugs to prevent rejection, as well as ongoing monitoring for complications. Innovations in both transplant techniques and alternative therapies like gene therapy and stem cell treatments are paving the way for improved outcomes in these patients, offering hope for those with end-stage heart failure.
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Yong Xiao Wang
Albany Medical Center, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Yong Xiao Wang
Albany Medical Center, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United StatesSubmit your abstract Today
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt
Title : Successful treatment of sinus of valsalva aneurysm
Aina Jarillo, Universidad Anahuac Mexico Norte, Mexico